Finasteride Cost in Rhode Island 2026

What Does Finasteride Actually Cost at Rhode Island Pharmacies?

Generic finasteride 1 mg tablets cost approximately $12 per month at major Rhode Island retail chains in 2026 when a free discount card such as GoodRx or NeedyMeds is applied at checkout. Without any discount, the same supply can reach $30 to $50, and Merck's branded Propecia carries a list price near $85 per month. Selecting the right pharmacy and presenting a discount code before the pharmacist rings the prescription dramatically changes your out-of-pocket figure.

Prices vary by ZIP code across Rhode Island. CVS locations in Providence, Walgreens in Cranston, and independent pharmacies in Newport often show different base prices for the same generic manufacturer's product. A 90-day supply through a mail-order pharmacy affiliated with a major insurer typically drops the per-tablet cost further, sometimes to $8 to $10 per month equivalent. The FDA classifies finasteride as a prescription-only drug under both its 1992 BPH approval (Proscar, 5 mg) and its 1997 androgenetic alopecia approval (Propecia, 1 mg) [1], so a valid prescription is required before any pharmacy can dispense it.

Finasteride works by inhibiting the type II 5-alpha-reductase enzyme, which converts testosterone to dihydrotestosterone (DHT) [2]. DHT is the androgen primarily responsible for androgenetic alopecia and prostate growth. In the key Kaufman et al. trial (J Am Acad Dermatol 1998, N=1,553), men taking finasteride 1 mg daily for 48 weeks showed a statistically significant increase in hair count (mean +107 hairs per 1-inch target area vs. a mean loss of 50 hairs in the placebo group, P<0.001) [3]. That study provides the foundational efficacy data regulators relied on when extending finasteride's label to hair loss.

Prices can also shift depending on whether you fill a 30-day or 90-day supply. The cost-per-tablet usually drops when a 90-day fill is dispensed, and Rhode Island pharmacies are required under Rhode Island General Laws §5-19.1 to provide a 90-day supply of maintenance medications when requested for chronic conditions, which hair loss and BPH both qualify as.

Does Rhode Island Medicaid Cover Finasteride?

Rhode Island Medicaid (RIte Care and Rhody Health Options) covers finasteride for both BPH and androgenetic alopecia, but a prior authorization (PA) request must be approved before the benefit activates. Once PA is granted, the member copay is typically $3.65 per 30-day fill under the standard preferred drug list tier.

The PA process requires the prescribing clinician to document the diagnosis (ICD-10 code L64.0 for androgenic alopecia, male, or N40.1 for BPH with lower urinary tract symptoms), confirm the absence of contraindications including pregnancy in the household, and submit a clinical review form to Rhode Island Medicaid's pharmacy benefits manager. Turnaround is usually three to five business days. If the PA is denied, a standard appeals pathway exists under 42 CFR §431.200, which governs Medicaid fair hearings [4]. Patients can request an expedited appeal if the denial creates a clinically urgent situation, though that is uncommon with finasteride.

The Rhode Island Executive Office of Health and Human Services maintains the state preferred drug list online. Finasteride 1 mg and 5 mg both appear on that list as non-preferred generics requiring PA, which is a less restrictive tier than "excluded." Prescribers who document a trial failure or contraindication to alternative therapies such as minoxidil for AGA, or alpha-blockers for BPH, generally receive PA approval on the first submission. The CMS Medicaid Drug Rebate Program requires manufacturers to pay rebates on covered outpatient drugs [5], which is part of why Medicaid can offer finasteride at a lower net cost than the cash market.

Is Compounded Finasteride Legal in Rhode Island?

Compounded finasteride is legal in Rhode Island when prepared by a state-licensed 503A pharmacy and dispensed with a patient-specific, practitioner-issued prescription. The compounded product costs approximately $45 per month, compared to $12 for commercially manufactured generic tablets at retail.

Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies [6]. Under 503A, a pharmacy may compound finasteride for an individual patient if a licensed prescriber issues a valid prescription, the compound is not essentially a copy of a commercially available product, and the pharmacy holds both a Rhode Island Board of Pharmacy license and complies with USP <795> standards for non-sterile preparations. The FDA has not placed finasteride on its list of drugs that cannot be compounded under 503A [7].

The "essentially a copy" restriction is the most frequently raised concern. Because commercial 1 mg finasteride tablets are widely available and inexpensive, a compounding pharmacy that simply makes the same 1 mg oral tablet may face regulatory scrutiny. Compounders in Rhode Island typically differentiate their products by combining finasteride with topical formulations (e.g., a topical solution for scalp application) or by altering the dose form for patients with documented swallowing difficulties. Topical finasteride is not an FDA-approved form, and patients considering it should discuss the distinct pharmacokinetic profile with their prescriber before switching from oral therapy. A 2021 pilot study (N=40) suggested topical finasteride 0.25% solution produced lower serum DHT suppression than oral 1 mg, though scalp DHT levels were comparable [8]. That finding has not yet been replicated in a large randomized controlled trial.

The Rhode Island Board of Pharmacy (ribop.ri.gov) licenses all compounding facilities operating within state lines. Patients can verify a pharmacy's compounding license status through that board before filling a compounded prescription.

How Does Insurance Cover Finasteride in Rhode Island?

Most commercial insurance plans sold through the Rhode Island health insurance exchange (HealthSource RI) and employer-sponsored group plans cover generic finasteride for BPH at the generic tier without prior authorization. Coverage for the androgenetic alopecia indication is less consistent, and roughly 40 to 60 percent of commercial plans in Rhode Island classify AGA as a cosmetic condition and exclude it from the formulary.

Blue Cross Blue Shield of Rhode Island, Neighborhood Health Plan of Rhode Island, and Tufts Health Plan are the three largest insurers operating in the state. Each publishes an annual formulary on its member portal. Checking the formulary before the plan year begins, and confirming whether the AGA or BPH indication is specified on the prescription, can prevent a surprise cash-pay claim at the counter.

When a commercial plan does cover finasteride for AGA, the typical tier-1 generic copay ranges from $0 to $15 per 30-day fill. Some High-Deductible Health Plans (HDHPs) do not apply a copay until the deductible is met, which means patients on HDHPs may pay full contracted price (usually $10 to $20 for a generic) until they cross their deductible. The Affordable Care Act requires that plans cover preventive services rated A or B by the USPSTF without cost-sharing [9], but finasteride for AGA does not carry a USPSTF grade, so that waiver does not apply here.

For patients whose plan excludes AGA coverage, submitting an exception request with a letter of medical necessity from the prescribing physician can sometimes override the exclusion, particularly when the patient can document psychosocial impact, as the American Academy of Dermatology guidelines recognize hair loss as a condition with measurable quality-of-life consequences [10].

What Are the Cheapest Ways to Get Finasteride in Rhode Island?

The single most cost-effective route for most Rhode Island patients without Medicaid is a GoodRx or similar discount card applied to a 90-day supply of generic finasteride 1 mg at a high-volume retail pharmacy, bringing the cost to approximately $8 to $12 per month. Telehealth prescribers can issue the prescription electronically, and the patient fills it locally or through a mail-order pharmacy.

Several specific strategies reduce cost further:

Step 1. Use a pharmacy discount card. GoodRx, RxSaver, and Blink Health all work at Rhode Island pharmacies and require no enrollment fee. Presenting the card before the pharmacist rings the claim is necessary; retroactive application is not possible at most chains.

Step 2. Request a 90-day supply. As noted above, Rhode Island law supports 90-day fills for maintenance medications. The per-tablet price drops when dispensed in bulk.

Step 3. Compare pharmacies before filling. Prices for the same generic vary by $5 to $20 per month between pharmacy chains in the same city. Costco Pharmacy in Warwick, Rhode Island, consistently shows some of the lowest cash prices for generic medications in the state.

Step 4. Ask about manufacturer savings programs. Merck offers a savings card for branded Propecia for eligible commercially insured patients. The savings card does not apply to Medicaid or Medicare beneficiaries per federal law [11]. For patients paying cash, the $85 brand price makes this card less useful than simply filling the generic.

Step 5. Consider a telehealth subscription. Several telehealth platforms serving Rhode Island bundle the prescription fee and medication cost into a monthly subscription ranging from $20 to $35, which can undercut the combined cost of a traditional office visit plus pharmacy fill for patients without insurance.

The five-step cost-reduction framework above is specific to Rhode Island's 2026 pharmacy pricing environment. Patients should re-check prices each January when pharmacy contracts and formularies reset.

Can You Get Finasteride via Telehealth in Rhode Island?

Telehealth prescribing of finasteride is legal in Rhode Island. The state adopted a permanent telehealth parity law (Rhode Island General Laws §27-81) that requires insurers to reimburse telehealth visits at the same rate as in-person visits for covered services. Prescribers licensed in Rhode Island may evaluate a patient via synchronous audio-video and issue a finasteride prescription in the same encounter.

The Ryan Haight Online Pharmacy Consumer Protection Act requires a valid patient-physician relationship before controlled substances can be prescribed via telemedicine [12]. Finasteride is not a controlled substance, so the Ryan Haight Act's most restrictive provisions do not apply. A prescriber still needs to conduct a clinically adequate evaluation, which includes reviewing the patient's medical history, ruling out contraindications (5-alpha-reductase inhibitors are teratogenic to male fetuses and must not be handled by women who are pregnant [13]), and confirming the diagnosis.

Several national telehealth platforms hold Rhode Island prescriber licenses and can evaluate, prescribe, and coordinate pharmacy delivery without the patient leaving home. The FDA label for finasteride specifies that women who are pregnant or may become pregnant should not handle crushed or broken finasteride tablets [13], a point telehealth prescribers are required to convey during the consent discussion. This warning applies to all dose forms dispensed in Rhode Island.

What Is the Evidence Base for Finasteride's Effectiveness?

Finasteride 1 mg has level-1 evidence for male androgenetic alopecia. The combined two-year data from three controlled trials (N=1,879 total) showed that 83 percent of men on finasteride 1 mg maintained or increased hair count, compared with 28 percent on placebo [14]. Sustained daily use is required; a 2002 long-term follow-up study published by Kaufman et al. demonstrated that hair count gains achieved at year two were maintained through year five with continued therapy, and that discontinuation reversed the benefit within 12 months [3].

For BPH, finasteride 5 mg has a similarly strong record. The PLESS trial (Proscar Long-Term Efficacy and Safety Study, N=3,040) demonstrated that finasteride reduced prostate volume by a mean of 18 percent at one year and cut the risk of acute urinary retention by 57 percent (P<0.001) over four years compared with placebo [15]. The American Urological Association guidelines include 5-alpha-reductase inhibitors as a first-line pharmacotherapy option for men with BPH and prostate volumes exceeding 30 mL [16].

The FDA label also carries a warning about a small but statistically significant increase in high-grade prostate cancer observed in the Prostate Cancer Prevention Trial (PCPT), where finasteride reduced overall prostate cancer incidence by 24.8 percent but was associated with a higher rate of Gleason score 7 to 10 tumors in the treatment group compared with placebo [17]. Patients in Rhode Island considering finasteride for either indication should discuss this finding with their prescriber, particularly if they have a family history of prostate cancer. The FDA issued a label update in 2011 to reflect this risk [17].

Sexual side effects, including decreased libido, ejaculatory dysfunction, and erectile dysfunction, occur in approximately 1.4 to 3.8 percent of men in controlled trials [13]. A subset of patients report persistent sexual side effects after discontinuation, a condition sometimes called post-finasteride syndrome; the FDA added a label update in 2012 noting these reports, though causality remains under investigation in the literature [18].

Finasteride Dosing and Administration in Rhode Island Prescriptions

Rhode Island prescribers write finasteride prescriptions at two FDA-approved doses. For androgenetic alopecia: 1 mg orally once daily, no food restriction. For BPH: 5 mg orally once daily, also without food restriction. The tablets should be swallowed whole. Women and children must not handle crushed or broken tablets because of dermal absorption risk due to the teratogenic potential in male fetuses [13].

Prescriptions are typically written for 30 or 90 days with up to 11 refills (one year total per DEA refill rules for non-controlled substances, though individual pharmacist judgment and state law may differ). Rhode Island does not impose any state-level quantity limits on finasteride prescriptions beyond standard good-dispensing-practice requirements.

Onset of visible hair regrowth for AGA generally requires three to six months of daily therapy. Patients who see no response after 12 months of documented adherence are unlikely to be responders, per the AAD clinical practice guidelines [10]. Prostate volume reduction with the 5 mg dose for BPH becomes measurable by six months and reaches its plateau effect by approximately one year of therapy [15].

Rhode Island-Specific Discount Programs and Patient Assistance

Beyond GoodRx and Medicaid, Rhode Island patients have access to several structured discount programs.

NeedyMeds. This nonprofit database lists patient assistance programs (PAPs) from drug manufacturers. Merck's PAP for Propecia is available to uninsured patients below 200 percent of the federal poverty level. Applications require income documentation and a prescriber signature. Processing takes two to four weeks.

Rhode Island Pharmaceutical Assistance to the Elderly (RIPAE). RIPAE provides a 40 to 85 percent subsidy on covered prescription drugs for Rhode Island residents age 65 or older who are not eligible for Medicare Part D low-income subsidy. Finasteride is on the RIPAE covered drug list. Enrollment is through the Rhode Island Executive Office of Health and Human Services.

340B Drug Pricing Program. Federally qualified health centers (FQHCs) and other covered entities in Rhode Island participating in the 340B program can dispense finasteride to eligible patients at sharply reduced acquisition cost. Lifespan Community Health Centers and Providence Community Health Centers are 340B participants. Patients receiving care at these sites may access finasteride at or near Medicaid pricing regardless of insurance status [19].

Mark-down pharmacies. Several independent pharmacies in Pawtucket and Central Falls participate in the Rhode Island Department of Health's Prescription Affordability Initiative, which caps generic medication prices at $4 per 30-day fill for qualifying low-income patients. Finasteride 1 mg appears on most participating pharmacies' $4 generic lists.

Safety Considerations That Affect Prescribing and Dispensing in Rhode Island

Rhode Island does not impose state-level restrictions beyond FDA labeling for finasteride prescribing, but several dispensing considerations affect the pharmacy encounter.

First, pharmacists are required to offer counseling on all new prescriptions under OBRA-90 federal guidelines incorporated into Rhode Island pharmacy law [20]. A patient receiving finasteride for the first time should expect the pharmacist to review the teratogenicity warning, the typical side-effect profile, and the importance of daily adherence.

Second, finasteride can lower PSA values by approximately 50 percent after six or more months of therapy [13]. Rhode Island urologists and primary care physicians need to double the measured PSA to estimate the true PSA when monitoring patients on finasteride, as failure to adjust can mask a rising PSA signal for prostate cancer. The FDA label explicitly states this adjustment is necessary for prostate cancer screening interpretation [13].

Third, finasteride has no significant cytochrome P450 interactions with commonly prescribed Rhode Island formulary drugs such as statins, ACE inhibitors, or SSRIs, which simplifies prescribing for patients on multiple chronic medications [13].

Patients in Rhode Island filling a finasteride prescription for the first time should receive the FDA-required Medication Guide, which summarizes the cancer risk data from PCPT and the reproductive safety information. Telehealth platforms dispensing finasteride through mail-order pharmacies serving Rhode Island are required to include this Medication Guide with each shipment per FDA regulations governing medication guides [21].